These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2832404)

  • 1. Inhibition of RNA polymerase I-directed transcription by novobiocin. Potential use of novobiocin as a general inhibitor of eukaryotic transcription initiation.
    Webb ML; Jacob ST
    J Biol Chem; 1988 Apr; 263(10):4745-8. PubMed ID: 2832404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novobiocin inhibits initiation of RNA polymerase II-directed transcription of the mouse metallothionein-I gene independent of its effect on DNA topoisomerase II.
    Webb ML; Maguire KA; Jacob ST
    Nucleic Acids Res; 1987 Oct; 15(20):8547-60. PubMed ID: 2823231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novobiocin inhibits RNA polymerase III transcription in vitro by a mechanism distinct from DNA topoisomerase II.
    Gottesfeld JM
    Nucleic Acids Res; 1986 Mar; 14(5):2075-88. PubMed ID: 3008085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novobiocin interferes with the binding of transcription factors TFIIIA and TFIIIC to the promoters of class III genes.
    Van Dyke MW; Roeder RG
    Nucleic Acids Res; 1987 Jun; 15(11):4365-74. PubMed ID: 3588299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of DNA gyrase in the transcription of ribosomal RNA.
    Oostra BA; Gruber M
    Nucleic Acids Res; 1980 Sep; 8(18):4235-46. PubMed ID: 6253912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-specific transactivators counteract topoisomerase II-mediated inhibition of in vitro transcription by RNA polymerases I and II.
    Brou C; Kuhn A; Staub A; Chaudhary S; Grummt I; Davidson I; Tora L
    Nucleic Acids Res; 1993 Aug; 21(17):4011-8. PubMed ID: 8396762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro transcription by Xenopus oocytes RNA polymerase III requires a DNA topoisomerase II activity.
    Glikin GC; Blangy D
    EMBO J; 1986 Jan; 5(1):151-5. PubMed ID: 3007112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene.
    Garg LC; DiAngelo S; Jacob ST
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3185-8. PubMed ID: 3033639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase.
    Willmott CJ; Critchlow SE; Eperon IC; Maxwell A
    J Mol Biol; 1994 Sep; 242(4):351-63. PubMed ID: 7932695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novobiocin inhibits interactions required for yeast TFIIIB sequestration during stable transcription complex formation in vitro.
    Felts SJ; Weil PA; Chalkley R
    Nucleic Acids Res; 1987 Feb; 15(4):1493-506. PubMed ID: 3547336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase IIα promotes activation of RNA polymerase I transcription by facilitating pre-initiation complex formation.
    Ray S; Panova T; Miller G; Volkov A; Porter AC; Russell J; Panov KI; Zomerdijk JC
    Nat Commun; 2013; 4():1598. PubMed ID: 23511463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of DNA gyrase on the transcription of linear DNA in vitro.
    Shmerling ZhG; Gragerov AI
    FEBS Lett; 1982 Apr; 140(2):260-2. PubMed ID: 6282640
    [No Abstract]   [Full Text] [Related]  

  • 13. The positive transcription factor of the 5S RNA gene induces a 5S DNA-specific gyration in Xenopus oocyte extracts.
    Kmiec EB; Worcel A
    Cell; 1985 Jul; 41(3):945-53. PubMed ID: 2408763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of DNA gyrase in rRNA synthesis in vivo.
    Wahle E; Mueller K
    Mol Gen Genet; 1980; 179(3):661-7. PubMed ID: 6255288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1993 Nov; 53(22):5487-93. PubMed ID: 8106148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
    Robinson MJ; Corbett AH; Osheroff N
    Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA polymerase (rpoB) mutants selected for increased resistance to gyrase inhibitors in Salmonella typhimurium.
    Blanc-Potard AB; Gari E; Spirito F; Figueroa-Bossi N; Bossi L
    Mol Gen Genet; 1995 Jun; 247(6):680-92. PubMed ID: 7616959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of stable preinitiation complexes is a prerequisite for ribosomal DNA transcription in vitro.
    Wandelt C; Grummt I
    Nucleic Acids Res; 1983 Jun; 11(11):3795-809. PubMed ID: 6856465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A purified fraction containing RNA polymerase I that can accurately transcribe rat ribosomal RNA gene.
    Kurl RN; Rothblum LI; Jacob ST
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6672-5. PubMed ID: 6593724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of cycloheximide upon transcription of rRNA, 5 S RNA, and tRNA genes.
    Gokal PK; Cavanaugh AH; Thompson EA
    J Biol Chem; 1986 Feb; 261(6):2536-41. PubMed ID: 2419318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.